ACM has now delivered the post-earnings drop that insiders bet against — and the Street's response has been swift, unanimous, and brutal on price targets.
The results landed on August 10, and the stock fell 11.6% in a single session, closing Tuesday at $67.05. That's exactly the pattern that played out after the prior quarter — a double-digit day-one move — and it has erased the remaining gap between the current price and where CEO Troy Rudd, CFO Gaurav Kapoor, and President Lara Poloni were buying in May and June. The three executives collectively spent nearly $700,000 in open-market purchases at prices between $70.63 and $71.12. The stock is now trading below every one of those entry points.
The analyst response this week has been a coordinated target reset rather than a sentiment shift. Every firm that updated — Citigroup, Truist, Keybanc, Barclays, and Baird — cut their price targets, some aggressively. Citigroup's Andrew Kaplowitz moved from $97 to $84. Truist's Jamie Cook dropped from $102 to $85. Keybanc came down from $101 to $79. None of them changed their ratings: bulls stayed bullish, neutrals stayed neutral. The consensus mean price target now sits around $88.83, implying roughly 32% upside from current levels — a wide gap that reflects the Street's view that the sell-off has overshot fair value, not that the thesis is broken. The bear case centres on margin pressure from AI-related investments and delayed free cash flow recovery from claims resolutions. Bulls point to record backlog, strong secular exposure to infrastructure spending, and a capital return story that remains intact.
Positioning around the stock tells a quieter story than the price action suggests. Short interest at 5.6% of the free float is a meaningful level but has actually fallen this week — down nearly 8% from Monday's open — indicating bears trimmed rather than pressed after the print. Borrowing costs are low at just 0.41% and declining. Borrow availability is extremely loose, with roughly 5,893% availability, meaning there is no supply constraint on new shorts and no mechanical squeeze pressure building. The options market is similarly measured: the put/call ratio of 0.76 is only fractionally above its 20-day average of 0.73, and the z-score of 0.28 shows no meaningful rush for downside protection beyond what's already been priced in. Combined with the ORTEX short score easing to 40.8 — down from 43.3 just two weeks ago — the positioning picture looks more like controlled retreat than capitulation or panic.
The factor scores add texture to the bull-bear divide. The EPS surprise rank sits in just the 4th percentile — the company has a persistent habit of coming in light on the bottom line relative to expectations. EPS momentum over both 30 and 90 days is also weak, ranking in the 34th and 37th percentiles respectively. The dividend score at the 88th percentile and an EV/EBIT rank in the 64th percentile suggest the valuation support is real, but it hasn't been enough to arrest the momentum bleed: STN and WSP — the two most correlated peers — both gained on the week, up 1.6% and 10.1% respectively, widening ACM's relative underperformance even within the engineering services group.
The next scheduled earnings event is November 16. Between now and then, the key variables to track are whether management commentary on the claims-resolution timeline gains credibility, whether the AI investment drag shows any sign of peaking in the cost base, and whether the insider purchases made in May and June prove to have been the floor or merely an early station on the way down.
See the live data behind this article on ORTEX.
Open ACM on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
